These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35724634)

  • 1. The Treatment of Substance Use Disorders: Recent Developments and New Perspectives.
    Rosenthal A; Ebrahimi C; Wedemeyer F; Romanczuk-Seiferth N; Beck A
    Neuropsychobiology; 2022; 81(5):451-472. PubMed ID: 35724634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurobiology of cue-reactivity, craving, and inhibitory control in non-substance addictive behaviors.
    Antons S; Brand M; Potenza MN
    J Neurol Sci; 2020 Aug; 415():116952. PubMed ID: 32534370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Learning to forget: manipulating extinction and reconsolidation processes to treat addiction.
    Torregrossa MM; Taylor JR
    Psychopharmacology (Berl); 2013 Apr; 226(4):659-72. PubMed ID: 22638814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Virtual reality exposure therapy for treating addictions and craving].
    Bouzegaou R; Kuntz A; Gothuey I
    Rev Med Suisse; 2022 Jun; 18(785):1143-1145. PubMed ID: 35678343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mindfulness-based relapse prevention combined with virtual reality cue exposure for methamphetamine use disorder: Study protocol for a randomized controlled trial.
    Chen XJ; Wang DM; Zhou LD; Winkler M; Pauli P; Sui N; Li YH
    Contemp Clin Trials; 2018 Jul; 70():99-105. PubMed ID: 29679670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonpharmacologic approaches to substance abuse treatment.
    Carroll KM; Schottenfeld R
    Med Clin North Am; 1997 Jul; 81(4):927-44. PubMed ID: 9222261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Invasive and Non-Invasive Brain Modulation Interventions for Addiction.
    Luigjes J; Segrave R; de Joode N; Figee M; Denys D
    Neuropsychol Rev; 2019 Mar; 29(1):116-138. PubMed ID: 30536145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of neuromodulation on cognitive performance in individuals exhibiting addictive behaviour: a systematic review protocol.
    Naish KR; Vedelago L; MacKillop J; Amlung M
    Syst Rev; 2018 Jun; 7(1):90. PubMed ID: 29945682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of virtual reality in craving assessment and cue-exposure therapy in substance use disorders.
    Hone-Blanchet A; Wensing T; Fecteau S
    Front Hum Neurosci; 2014; 8():844. PubMed ID: 25368571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental medicine in drug addiction: towards behavioral, cognitive and neurobiological biomarkers.
    Duka T; Crombag HS; Stephens DN
    J Psychopharmacol; 2011 Sep; 25(9):1235-55. PubMed ID: 21169391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theories of drug craving, ancient and modern.
    Drummond DC
    Addiction; 2001 Jan; 96(1):33-46. PubMed ID: 11177518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mini-review: When neurostimulation joins cognitive-behavioral therapy. On the need of combining evidence-based treatments for addiction disorders.
    Perrotta D; Perri RL
    Neurosci Lett; 2022 Apr; 777():136588. PubMed ID: 35341891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. tDCS in Addiction and Impulse Control Disorders.
    Lapenta OM; Marques LM; Rego GG; Comfort WE; Boggio PS
    J ECT; 2018 Sep; 34(3):182-192. PubMed ID: 30095681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitionality in addiction: A "temporal continuum" hypotheses involving the aberrant motivation, the hedonic dysregulation, and the aberrant learning.
    Patrono E; Gasbarri A; Tomaz C; Nishijo H
    Med Hypotheses; 2016 Aug; 93():62-70. PubMed ID: 27372858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions with potential to target executive function deficits in addiction: current state of the literature.
    Lechner WV; Sidhu NK; Kittaneh AA; Anand A
    Curr Opin Psychol; 2019 Dec; 30():24-28. PubMed ID: 30797130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the Choice Behavior Under Cued Conditions (CBUCC) paradigm as a measure of motivation to smoke under laboratory conditions.
    Gass JC; Tiffany ST
    Addiction; 2020 Feb; 115(2):302-312. PubMed ID: 31390087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reward-related brain response and craving correlates of marijuana cue exposure: a preliminary study in treatment-seeking marijuana-dependent subjects.
    Goldman M; Szucs-Reed RP; Jagannathan K; Ehrman RN; Wang Z; Li Y; Suh JJ; Kampman K; O'Brien CP; Childress AR; Franklin TR
    J Addict Med; 2013; 7(1):8-16. PubMed ID: 23188041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addiction and brain reward and antireward pathways.
    Gardner EL
    Adv Psychosom Med; 2011; 30():22-60. PubMed ID: 21508625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an effective virtual environment in eliciting craving in adolescents and young adults with internet gaming disorder.
    Shin YB; Kim JJ; Kim MK; Kyeong S; Jung YH; Eom H; Kim E
    PLoS One; 2018; 13(4):e0195677. PubMed ID: 29672530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retraining the addicted brain: a review of hypothesized neurobiological mechanisms of mindfulness-based relapse prevention.
    Witkiewitz K; Lustyk MKB; Bowen S
    Psychol Addict Behav; 2013 Jun; 27(2):351-365. PubMed ID: 22775773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.